Tianjin Lisheng Plans RMB 1 Billion Fund with Strategic Partners
Tianjin Lisheng Pharmaceutical Co., Ltd. (SHE: 002393), based in China, announced plans to co-establish the...
Finance
Haohai Biotech Terminates OK Lens Distribution Deal with Brighten Optix Amid Carl Zeiss Acquisition
Shanghai Haohai Biological Technology Co., Ltd. (HKG: 6826, SHA: 688366) announced the termination of its...
Vivatides Therapeutics Completes Multi-Million Dollar Seed Financing to Advance Nucleic Acid Delivery Platform
Biopharmaceutical company Vivatides Therapeutics has successfully completed a multi-million dollar seed round financing led by...
Sino Biopharmaceutical on Track to Receive $300M Milestone Payment for PD-1/VEGF Antibody Deal
China-based Sino Biopharmaceutical Ltd (HKG: 1177) has announced that the out-licensing collaboration between its subsidiary...
Shanghai Biomedicine M&A Fund Acquires Stake in MicroPort via Share Transfer Agreement
The Shanghai Biomedicine Merger and Acquisition Fund under SIIC Capital has entered into a share...
Tibet Aim Pharm’s Major Shareholder Transfers Stake to Beijing Fuhao
China-based Tibet Aim Pharm, Inc. (SHE: 002826) announced that its controlling shareholder and actual controller,...
Velavigo Closes $60 Million Pre-A+ Financing Round to Advance Global Clinical Trials
Velavigo, a Shanghai-based pharmaceutical startup, has reportedly secured USD 60 million in a Pre-A+ financing...
Everest Medicines Completes HK$1.57 Billion Share Placement to Advance R&D and Commercialization
China-based Everest Medicines (HKG: 1952) announced today the completion of a share placement of 22,561,000...
Shanghai Wankexin Biotech to Acquire Stake in Chengdu Kanghua Biological for RMB 1.851 Billion
Shanghai Wankexin Biotechnology Partnership Enterprise (Limited Partnership) (“Wankexin Biotech”), a subsidiary of the Shanghai Biomedicine...
VivaVision Biotech Closes D2+ Funding Round, Advancing Ophthalmic Therapies
VivaVision Biotech recently announced the successful closing of its D2+ funding round, raising 140 million...
Tcelltech Secures USD 40 Million Series B Funding for TX-103 CAR-T Therapy Development
China-based Tcelltech Ltd., a developer of T-cell immunotherapies, has reportedly secured close to USD 40...
Sino Biopharmaceutical Acquires Majority Stake in LaNova Medicines for USD 950.92 Million
China-based Sino Biopharmaceutical Ltd (HKG: 1177) announced the acquisition of a 95.09% stake in Shanghai-based...
ShuWen Biotech Completes RMB100 Million Series C1 Round to Advance Women’s Health Diagnostics
Zhejiang-based ShuWen Biotech Co., Ltd announced the successful completion of an RMB100 million (USD 14...
LakeShore Biopharma Secures $15 Million in Private Placement to Fuel Growth
China-based biopharmaceutical company LakeShore Biopharma Co., Ltd (NASDAQ: LSB) has announced the successful execution of...
Shenzhen Concemed Medtech Secures Hundreds of Millions in Series A+ Funding for Endoscopy Expansion
Shenzhen Concemed Medical Technology Co., Ltd., a China-based endoscope specialist, has reportedly secured “hundreds of...
Micot Raises Over RMB 100 Million in Series D Funding Led by Zheshang Venture Capital
Micot, a polypeptide new molecular entity (NME) drug developer with operations in mainland China, Hong...
Sanofi Invests $25 Million in China’s Adagene to Advance SAFEbody Program
French pharmaceutical major Sanofi (NASDAQ: SNY) is set to make a USD 25 million investment...
Sunshine Lake Pharma Lists on HKEX via Introduction Method
China-based Sunshine Lake Pharma Co., Ltd. (HKG: 6887) has successfully listed on the Main Board...
TINGSN Technology Secures RMB 100M in Series B+ Round for 4D Intracardiac Ultrasound R&D
China-based TINGSN Technology has reportedly secured RMB 100 million (USD 14 million) in a Series...
Illumina to Acquire SomaLogic for $350M to Expand Proteomics Tech Integration
US major Illumina (NASDAQ: ILMN) announced plans to acquire SomaLogic, a leader in data-driven proteomics...